In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice

Abstract

This study provides evidence for using CRISPR-based genome editing as a potential therapeutic approach for restoring dystrophic cardiomyopathy structurally and functionally.